000			02301nam a22004815i 4500
001			978-3-319-17275-0
003			DE-He213
005			20160405112859.0
007			cr nn 008mamaa
008			150611s2015 gw | s |||| 0|eng d
020			_a9783319172750 _9978-3-319-17275-0
024	7		_a10.1007/978-3-319-17275-0 _2doi
050		4	_aRC261-271
072		7	_aMJCL _2bicssc
072		7	_aMED062000 _2bisacsh
082	0	4	_a614.5999 _223
245	1	0	_aResistance to Immunotoxins in Cancer Therapy _h[electronic resource] / _cedited by Rama Shanker Verma, Benjamin Bonavida.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2015.
300			_aXVI, 249 p. 22 illus., 19 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	1		_aResistance to Targeted Anti-Cancer Therapeutics, _x2196-5501 ; _v6
520			_aThis volume is a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. It contains a detailed review of the history and development of targeted therapy. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance. Each chapter discusses different aspects of resistance and covers all the factors that may contribute to resistance in cancer cells. Finally, this volume highlights the recent findings and advances associated with tackling cancer resistance.
650		0	_aMedicine.
650		0	_aCancer research.
650		0	_aDrug resistance.
650		0	_aPharmacology.
650	1	4	_aBiomedicine.
650	2	4	_aCancer Research.
650	2	4	_aDrug Resistance.
650	2	4	_aPharmacology/Toxicology.
700	1		_aVerma, Rama Shanker. _eeditor.
700	1		_aBonavida, Benjamin. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783319172743
830		0	_aResistance to Targeted Anti-Cancer Therapeutics, _x2196-5501 ; _v6
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-319-17275-0
912			_aZDB-2-SBL
999			_c4033 _d4033